Utility of routine electrocardiographic screening before initiation of propranolol for infantile hemangiomas.
Pediatr Dermatol
; 35(4): e233-e234, 2018 Jul.
Article
en En
| MEDLINE
| ID: mdl-29683225
ABSTRACT
Screening electrocardiography (ECG) before initiation of propranolol for treatment of infantile hemangiomas (IH) is controversial. A retrospective chart review was conducted to assess the utility of pretreatment ECG in infants with IH starting propranolol. Although nearly half of the ECGs were abnormal, no contraindications to treatment were identified from screening ECG, and no association was found between any of the reported side effects and abnormal ECG. These results support previously published data, and in a larger cohort, providing further confirmation that pretreatment ECG is not necessary in most infants with IH.
Palabras clave
Texto completo:
1
Colección:
01-internacional
Banco de datos:
MEDLINE
Asunto principal:
Propranolol
/
Tamizaje Masivo
/
Antagonistas Adrenérgicos beta
/
Electrocardiografía
/
Hemangioma
Tipo de estudio:
Diagnostic_studies
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
/
Screening_studies
Límite:
Female
/
Humans
/
Infant
/
Male
Idioma:
En
Revista:
Pediatr Dermatol
Año:
2018
Tipo del documento:
Article
País de afiliación:
Estados Unidos